MS involves both inflammation and neurodegeneration from the outset, not just one after the other. B-cells, a type of immune cell, are now understood to be critical drivers of the disease, a major ...
FRANKFURT, April 30 (Reuters) - Merck KGaA has started a mid-stage trial to evaluate the safety and efficacy of atacicept in patients with relapsing multiple sclerosis, the German drugs and chemicals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback